Cutting edge: WIP, a binding partner for Wiskott-Aldrich syndrome protein, cooperates with Vav in the regulation of T cell activation

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 2866-2870

  Savoy, Doris N ^a   Billadeau, Daniel D ^a   Leibson, Paul J ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR;

ARTICLE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; WISKOTT ALDRICH SYNDROME;

EID: 0034654348     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.2866     Document Type: Article

References (24)

1. Derry, J. M., H. D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635.
2. Snapper, S. B., and F. S. Rosen. 1999. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annu. Rev. Immunol. 17:905.
3. Gallego, M. D., M. Santamaria, J. Pena, and I. J. Molina. 1997. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90:3089.
4. Badolato, R., S. Sozzani, F. Malacarne, S. Bresciani, M. Fiorini, A. Borsatti, A. Albertini, A. Mantovani, A. G. Ugazio, and L. D. Notarangelo. 1998. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalamne. J. Immunol. 161:1026.
5. Kolluri, R., K. F. Tolias, C. L. Carpenter, F. S. Rosen, and T. Kirchhausen. 1996. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase, Cdc42. Proc. Natl. Acad. Sci. USA 93:5615.
6. Ramesh, N., I. M. Anton, J. H. Hartwig, and R. S. Geha. 1997. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl. Acad. Sci. USA 94:14671.
7. Schwarz, K., S. Nonoyama, M. Peitsch, G. de Saint Basile, T. Espanol, A. Fasth, A. Fischer, K. Freitag, W. Friedrich, S. Fugmann, et al. 1996. WASPbase: a database of WAS- and XLT-causing mutations. Immunol. Today 17:496.
8. Stewart, D. M., L. Tian, and D. L. Nelson. 1999. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J. Immunol. 162:5019.
9. Snapper, S. B., F. S. Rosen, E. Mizoguchi, P. Cohen, W. Kahn, C.-H. Liu, T. L., Hagemann, S.-P. Kwan, R. Ferrini, L. Davidson, et al. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9:81.
10. Phatak, P. D., and C. H. Packman. 1994. Engagement of the T cell antigen receptor by anti-CD3 monoclonal antibody causes a rapid increase in lymphocyte F-actin. J. Cell. Physiol. 159:365.
11. Fischer, K.-D., Y.-Y. Kong, H. Nishina, K. Tedford, L. E. M. Marengere, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, S. Gardener, et al. 1998. Vav is a regulator of TCR-mediated cytoskeleton reorganization required for proliferation, interleukin 2 production, and T cell maturation. Curr. Biol. 8:554.
12. Holsinger, L. J., I. A. Graef, W. Swat, T. Chi, D. M. Baustista, L. Davidson, R. S. Lewis, F. W. Alt, and G. R. Crabtree. 1998. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563.
13. Holsinger, L. J., D. M. Spencer, D. J. Austin, S. L. Schreiber, and G. R. Crabtree. 1995. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 92:9810.
14. Wu, J., S. Katzav, and A. Weiss. 1995. A functional T-cell receptor signaling pathway is required for p95vav activity. Mol. Cell. Biol. 15:4337.
15. Billadeau, D., D. F. Jelinek, N. Shah, T. W. LeBien, and B. Van Ness. 1995. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin-6-dependent cell line ANBL6. Cancer Res. 55:3640.
16. Billadeau, D. D., K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo, and P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Esp. Med. 188:549.
17. Hedin, K. E., M. P. Bell, K. R. Kalli, C. J. Huntoon, B. M. Sharp, and D. J. McKean. 1997. δ-Opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159:5431.
18. Wu, J., D. G. Motto, G. A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593.
19. Anton, I. M., W. Lu, B. J. Mayer, N. Ramesh, and R. S. Geha. 1998. The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J. Biol. Chem. 273:20992.
20. Vaduva, G., N. Martinez-Quiles, I. M. Anton, N. C. Martin, R. S. Geha, A. K. Hopper, and N. Ramesh. The human WASP-interacting protein, WIP, activates the cell polarity pathway in yeast. J. Biol. Chem. 274:17103.
21. Olson, M. F., N. G. Pasteris, J. L. Gorski, and A. Hall. 1996. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr. Biol. 6:1628.
22. Crespo, P., K. E. Schuebel, A. A. Ostrom, S. J. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by vav proto-oncogene product. Nature 385:169.
23. Han, J., B. Das, W. Wei, L. Van Aelst, R. D. Mosteller, R. Khosravi-Far, J. K. Westwick, C. J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family of GTPases. Mol. Cell. Biol. 17:1346.
24. Yablonski, D., L. P. Kane, D. Qian, and A. Weiss. 1998. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J. 17:5647.